A detailed history of Bridgeway Capital Management, LLC transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 76,981 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,981
Previous 58,181 32.31%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
18,800 Added 32.31%
76,981 $0
Q1 2024

May 15, 2024

BUY
N/A
26,200 Added 81.92%
58,181 $0
Q4 2023

Feb 14, 2024

BUY
N/A
31,981 New
31,981 $0

Others Institutions Holding ACRV

About Acrivon Therapeutics, Inc.


  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.